Review of the 2nd day of the II Scientific and Practical Conference in a hybrid format “Achievements, problems and prospects in hematology”. Treatment and diagnosis of patients wit... por V. A. Shuvaev

Enlace del recurso

How we treat polycythemia vera por V. A. Shuvaev, I. S. Martynkevich

Enlace del recurso

All we know about polycythemia vera: literature review and own experience por K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Enlace del recurso

Dasatinib: ten years of clinical practice worldwide por K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Enlace del recurso

Primary myelofibrosis: own experience and news from diagnostic and treatment por K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Enlace del recurso

Primary myelofibrosis: own experience and news from diagnostic and treatment por K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Enlace del recurso

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission por V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Enlace del recurso

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission por V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Enlace del recurso

Pharmacoeconomic analysis of thrombopoietin receptor agonists in the treatment of chronic idiopathic thrombocytopenic purpura in adults por E. A. Pyadushkina, M. Yu. Frolov, V. A. Shuvaev, V. A. Rogov

Enlace del recurso

Clinical Case of Posterior Reversible Encephalopathy Syndrome in a Female Patient Undergoing Surgery for Rectal Cancer por M. M. Geraskinа, A. B. Galitsynа, V. A. Shuvaev, S. S. Gosteva

Enlace del recurso

Contemporary conceptions of etiology, pathogenesis, management and treatment of primary diffuse large b-cell central nervous system lymphoma por S. V. Voloshin, Yu. A. Krivolapov, A. V. Shmidt, V. A. Shuvaev, M. S. Fominykh, K. M. Abdulkadyrov

Enlace del recurso

Contemporary conceptions of etiology, pathogenesis, management and treatment of primary diffuse large b-cell central nervous system lymphoma por S. V. Voloshin, Yu. A. Krivolapov, A. V. Shmidt, V. A. Shuvaev, M. S. Fominykh, K. M. Abdulkadyrov

Enlace del recurso

Combination therapy with ruxolitinib plus low-dose cytarabine or mercaptopurine in patients with blast-phase myelofibrosis por M. S. Fominykh, V. A. Shuvaev, I. S. Martynkevich, L. B. Polushkina, V. Yu. Udal’eva, K. M. Abdulkadyrov

Enlace del recurso

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients por V. A. Shuvaev, M. S. Fominykh, I. S. Martynkevich, V. Y. Udaleva, N. A. Potikhonova, M. N. Zenina, K. M. Abdulkadyrov

Enlace del recurso

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients por V. A. Shuvaev, M. S. Fominykh, I. S. Martynkevich, V. Y. Udaleva, N. A. Potikhonova, M. N. Zenina, K. M. Abdulkadyrov

Enlace del recurso

Retrospective analysis of own long-term experience in studying the BCR::ABL kinase domain mutational status in patients with chronic myeloid leukemia por D. V. Kustova, E. V. Motyko, A. N. Kirienko, T. N. Gert, I. V. Leppyanen, M. P. Bakay, E. V. Efremova, E. V. Morozova, E. G. Lomaia, V. A. Shuvaev, S. V. Sidorkevich, I. S. Martynkevich

Enlace del recurso

THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA por A. A. Zhernyakova, I. S. Martynkevich, V. A. Shuvaev, L. B. Polushkina, M. S. Fominykh, V. Yu. Udal’eva, I. I. Zotova, D. I. Shiсhbabaeva, S. V. Voloshin, S. S. Бессмельцев, A. V. Chechetkin, K. M. Abdulkadyrov

Enlace del recurso

The use of non-cryopreserved hematopoietic stem cells for autologous transplantation in multiple myeloma patients por S. V. Voloshin, A. D. Garifullin, A. A. Kuzyaeva, N. N. Sinitsina, N. N. Alekseeva, A. V. Schmidt, S. Y. Linnikov, V. A. Shuvaev, A. Y. Kuvshinov, N. A. Potikhonova, A. V. Seltser, V. A. Balashova, Z. V. Chubukina, A. N. Bogdanov, S. V. Sidorkevich

Enlace del recurso

Results of following up patients with chronic myeloid leukemia and a deep molecular response without tyrosine kinase inhibitor therapy por A G Turkina, E Yu Chelysheva, V A Shuvaev, G A Gusarova, A V Bykova, O A Shukhov, A N Petrova, M V Vakhrusheva, S R Goryacheva, L Yu Kolosova, P S Krasikova, M S Fominykh, I S Martynkevich, A O Abdullaev, A B Sudarikov, V G Savchenko

Enlace del recurso